Related references
Note: Only part of the references are listed.MF59 adjuvant: the best insurance against influenza strain diversity
Derek T. O'Hagan et al.
EXPERT REVIEW OF VACCINES (2011)
Assessment of the safety, tolerability and kinetics of the immune response to A/H1N1v vaccine formulations with and without adjuvant in healthy pediatric subjects from 3 through 17 years of age
Adriano Arguedas et al.
HUMAN VACCINES (2011)
Influenza vaccine immunology
Philip R. Dormitzer et al.
IMMUNOLOGICAL REVIEWS (2011)
Antigen-stimulated CD4 T-cell expansion is inversely and log-linearly related to precursor number
Juan Quiel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Feedback regulation of proliferation vs. differentiation rates explains the dependence of CD4 T-cell expansion on precursor number
Gennady Bocharov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The need for quadrivalent vaccine against seasonal influenza
Robert B. Belshe
VACCINE (2010)
Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: Safety and immunogenicity of a phase 1/2 clinical trial
Wendy Keitel et al.
VACCINE (2010)
In Vitro Responses to Avian Influenza H5 by Human CD4 T Cells
Matthew F. Cusick et al.
JOURNAL OF IMMUNOLOGY (2009)
Randomized, Double-Blind Controlled Phase 3 Trial Comparing the Immunogenicity of High-Dose and Standard-Dose Influenza Vaccine in Adults 65 Years of Age and Older
Ann R. Falsey et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
MF59®-Adjuvanted H5N1 Vaccine Induces Immunologic Memory and Heterotypic Antibody Responses in Non-Elderly and Elderly Adults
Angelika Banzhoff et al.
PLOS ONE (2009)
Enhanced Immunogenicity of Seasonal Influenza Vaccines in Young Children Using MF59 Adjuvant
Timo Vesikari et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)
Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels
Grazia Galli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Granzyme B: Correlates with protection and enhanced CTL response to influenza vaccination in older adults
Janet E. McElhaney et al.
VACCINE (2009)
MF59-adjuvanted versus non-adjuvanted influenza vaccines: Integrated analysis from a large safety database
Michele Pellegrini et al.
VACCINE (2009)
Emerging vaccines for influenza
Pritish K. Tosh et al.
EXPERT OPINION ON EMERGING DRUGS (2008)
Healthy human subjects have CD4+ T cells directed against H5N1 influenza virus
Michelle Roti et al.
JOURNAL OF IMMUNOLOGY (2008)
Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: A randomized controlled trial
David Holland et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Safety and immunogenicity of an MF59™-adjuvanted subunit influenza vaccine in elderly Chinese subjects
Rongcheng Li et al.
Immunity & Ageing (2008)
Antibody induction by virosomal, MF59-adjuvanted, or conventional influenza vaccines in the elderly
Iris de Bruijn et al.
VACCINE (2007)
Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects
Robert B. Couch et al.
VACCINE (2007)
Assessing the burden of influenza and other respiratory infections in England and Wales
R. J. Pitman et al.
JOURNAL OF INFECTION (2007)
Immunosenescence: Role and measurement in influenza vaccine response among the elderly
Paul V. Targonski et al.
VACCINE (2007)
Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons
Wendy A. Keitel et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Antibody response to influenza vaccination in the elderly: A quantitative review
K Goodwin et al.
VACCINE (2006)
The impact of influenza on the health and health care utilisation of elderly people
DM Fleming et al.
VACCINE (2005)
The unmet need in the elderly: Designing new influenza vaccines for older adults
JE McElhaney
VACCINE (2005)
A new MF59-adjuvanted influenza vaccine enhances the immune response in the elderly with chronic diseases: Results from an immunogenicity meta-analysis
A Banzhoff et al.
GERONTOLOGY (2003)
Mortality associated with influenza and respiratory syncytial virus in the United States
WW Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Pandemic preparedness:: lessons learnt from H2N2 and H9N2 candidate vaccines
N Hehme et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2002)
Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly
DM Murasko et al.
EXPERIMENTAL GERONTOLOGY (2002)
Immunogenicity and efficacy of Russian live attenuated and US inactivated influenza vaccines used alone and in combination in nursing home residents
LG Rudenko et al.
VACCINE (2000)
Share Paper
